UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
- Conditions
- Interventions
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 62
- Registration Number
- NCT03838263
- Locations
- 🇫🇷
Institut Sainte Catherine, Avignon, France
🇫🇷Hopital Tenon, Paris, France
🇫🇷Hopital Europeen Georges Pompidou, Paris, France
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- UNICANCER
- Registration Number
- NCT03809455
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
- First Posted Date
- 2019-01-10
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 517
- Registration Number
- NCT03799835
- Locations
- 🇫🇷
Hôpital Cochin, Paris, France
🇫🇷Groupe Hospitalier Paris Saint Joseph, Paris, France
🇫🇷Hôpital privé de la Louvière, Lille, France
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
- Conditions
- Interventions
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 112
- Registration Number
- NCT03777813
- Locations
- 🇫🇷
Centre Oscar Lambret, CLCC UNICANCER, Lille, France
🇫🇷Hôpital Saint Louis, APHP, Paris, France
🇫🇷Hôpital Haut-Lévêque, Pessac, France
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
- First Posted Date
- 2018-12-13
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 327
- Registration Number
- NCT03774732
- Locations
- 🇫🇷
Hôpital Simone Veil Blois, Blois, France
🇫🇷Centre Hospitalier Dr Jean-Eric TECHER, Calais, France
🇫🇷CHRU de Brest, Brest, France
Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.
- Conditions
- Interventions
- First Posted Date
- 2018-10-29
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 80
- Registration Number
- NCT03722680
- Locations
- 🇫🇷
CHU de Clermont -Ferrand, Clermont-Ferrand, France
🇫🇷ICO - Site Paul Papin, Angers, France
🇫🇷CH Beauvais, Beauvais, France
Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas
- Conditions
- Interventions
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 89
- Registration Number
- NCT03722108
- Locations
- 🇫🇷
Centre de Cancérologie du Grand Montpellier, Montpellier, France
🇫🇷CHU Dupuytren, Limoges, France
🇫🇷Clinique de Flandre, Coudekerque-Branche, France
Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy
- First Posted Date
- 2018-10-05
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 79
- Registration Number
- NCT03697850
- Locations
- 🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Centre Georges Francois Leclerc, Dijon, France
🇫🇷Institut Bergonie, Bordeaux, France
My Personalized Breast Screening
- Conditions
- Interventions
- First Posted Date
- 2018-09-14
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 53142
- Registration Number
- NCT03672331
- Locations
- 🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
🇧🇪Institut Jules Bordet, Bruxelles, Belgium
🇮🇱Assuta Medical Center Ramat HaHayal, Tel Aviv, Israel
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
- Conditions
- Interventions
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 60
- Registration Number
- NCT03643133
- Locations
- 🇫🇷
CHU de Nice - Service d'oncologie hématologie pédiatrique, Nice, France
🇫🇷CHU Toulouse - Hôpital des Enfants - Service d'Hémato-Immuno-Oncologie, Toulouse, France
🇫🇷CHU de Caen - Service d'oncologie hématologie pédiatrique, Caen, France